Stability of the nicotinic acetylcholine receptor (AChR) at the cell surface is key to the correct functioning of the cholinergic synapse. Cholesterol (Chol) is necessary for homeostasis of AChR levels at the plasmalemma and for ion translocation. Here we characterize the endocytic pathway followed by muscle-type AChR in Chol-depleted cells (Chol -). Under such conditions the AChR is internalized by a ligand-, clathrin-and dynamin-independent mechanism. Expression of a dominant negative form of the small GTPase Rac1, Rac1N17, abolishes receptor endocytosis. Unlike the endocytic pathway in control CHO cells (1), accelerated AChR internalization proceeds even upon disruption of the actin cytoskeleton. Under Chol -conditions AChR internalization is furthermore found to require the activity of Arf6 and its effectors Rac1 and phospholipase D. The Arf6-dependent mechanism may constitute the default endocytic pathway followed by the AChR in the absence of external ligands, membrane Chol levels acting as a key homeostatic regulator of cell surface receptor levels.
The nicotinic acetylcholine receptor (AChR), the best characterized member of the Cys-loop family within the ligand-gated ion channel superfamily, is an integral membrane protein composed of five homologous subunits organized pseudo-symmetrically around a central pore (2) . Each subunit contains a relatively large extracellular domain, four hydrophobic transmembrane (TM) segments (M1-M4) connected by loops of varying length and ends with a short extracellular carboxy terminal domain. Three concentric rings can be distinguished in the AChR TM region (3) . The M2 TM segments of all subunits outline the inner ring and form the walls of the ion channel proper; M1 and M3 constitute the middle ring, and the M4 segments form the outer ring, which is in closer contact with the AChR lipid microenvironment (4) . Early studies demonstrated that the function of AChR depends on the immediate lipid environment and specific interactions between membrane protein and lipid molecules. These interactions are purported to be responsible for the maintenance of specific secondary structures required to support the ion channel activity of the AChR (5) .
AChR internalization in the CHO-K1/A5 clonal cell line and C2C12 muscle cells was recently reported to occur via a novel endocytic mechanism (1) that does not involve the canonical dynamin, clathrin or caveolin pathways (6) . This pathway is triggered by ligand binding to the receptor and requires the activity of the small GTPase Rac1 as well as the integrity of the cytoskeleton. Ligand binding to AChR induces autophosphorylation of c-Src kinase with the consequent activation of Rac1 (1) . AChR internalization was also triggered by antibody binding (1) , thus relating the internalization process to other pathological conditions such as those operative in the autoimmune disease mysthenia gravis (7;8) .
We have recently found that cholesterol (Chol), an endogenous lipid present at the postsynaptic membrane, contributes to the homeostasis of receptor levels at the plasmalemma (9;10). Chol has been found to be necessary for the formation and maintenance of AChR clusters; Chol depletion induces the fragmentation of these relatively large, micron-sized AChR assemblies (11) (12) (13) (14) .
Likewise, the supramolecular organization of the AChR is influenced by Chol levels: Chol depletion increases the dimensions of AChR nanometer-sized clusters and changes the long-range distribution of nanoclusters at the cell surface (15) . Acceleration of the endocytic internalization of cell-surface AChR by Chol depletion (10) is unusual in that all known endocytic mechanisms are hindered upon diminution of cellular Chol levels (6) . In the present work we characterize this unusual modulatory effect induced by Chol on cell-surface AChR endocytosis. The endocytic mechanism disclosed here consists of the internalization of receptors via a pathway involving the activity of the small GTPase Arf6 and its effectors Rac1 and phospholipase D, but independent of the integrity of the actin network.
in cells with normal Chol levels over the period studied (Supp. Fig. 1 ). Fluorescence transferring and plasmids coding for Rab5-GFP and Rab7-GFP were kindly provided by Dr. J. L. Daniotti, CIQUIBIC, Cordoba, Argentina. Cell culture. CHO-K1/A5 cells were grown in Ham's F12 medium supplemented with 10% fetal bovine serum (FBS) for 2-3 days at 37°C as previously described (16) . Transient transfections. In some experiments CHO-K1/A5 cells were transiently transfected using Lipofectamine according to the protocol provided by the manufacturer. Cells were used for fluorescence microscopy 12 h after transfection. Acute Chol depletion/ replenishment of cultured cells. CHO-K1/A5 cells were treated with CDx in medium 1 (140 mM NaCl, 1 mM CaCl 2 , 1 mM MgCl 2 and 5 mM KCl in 20 mM HEPES buffer, pH 7.4) for 30 min at 37°C to acutely deplete their Chol content prior to fluorescent labeling as previously described (10) . Except for Fig. 1 , all experiments were carried out using a final concentration of 15 mM CDx. For Chol replenishment CDx-Chol complexes were prepared as in (17) . CHO-K1/A5 cells were incubated with 15 mM Chol-CDx complexes (CDx:Chol 6:1) at 37°C for 30 min. Biochemical assays. Lipids were extracted from cell suspensions for 3 h at room temperature in chloroform:methanol: water (1:2:0.8, by vol.) following the procedure of Bligh and Dyer (18) . Chol determination was carried out using the colorimetric Colestat kit (Wiener Lab, Rosario, Argentina). Disruption/stabilization of actin meshwork. Cytochalasin D stock solution was made in DMSO, and working solutions were prepared upon dilution of the stock in medium 1. The amount of DMSO was kept below 0.5% (v/v). In order to disrupt the cytoskeletal meshwork, CHO-K1/A5 cells were incubated with 12.5 µM Latrunculin A, 2.5 µM Cytochalasin D or 1 µM Jasplakinolide together with 15 mM CDx. Treatment of control cells with similar amounts of DMSO did not show alteration of cellular morphology or receptor internalization kinetics (see Fig. 3 ). Wide-field fluorescence microscopy. Cell-surface AChR labeling was carried out by incubating the cells in fluorescent-BTX for 1 h in chilled medium 1 on ice. The cells were then examined with a Nikon Eclipse E-600 microscope. Imaging was done with an SBIG model ST-7 digital charge-coupled device camera (765×510 pixels, 9.0×9.0 μm pixel size; Santa Barbara, CA, USA). The ST-7 CCD camera was driven by the CCDOPS software package (SBIG Astronomical Instruments, version 5.02). For all experiments 40x (1.0 N.A.) or 60x (1.4 N.A.) oil-immersion objectives were used. Appropriate dichroic and emission filters were employed to avoid crossover of fluorescence emission. Eight-bit or 16-bit TIFF images were exported for further off-line analysis. Confocal microscopy. Cells initially labeled with fluorescent αBTX for 1 h at 4°C were shifted to 37°C for 30 min in the presence of CDx or medium 1, respectively. Confocal images were obtained with a TCS-SP2 confocal microscope (Leica Mikrosysteme Vertrieb GmbH, Wetzlar, Germany) equipped with an acousto-optical beam splitter. Quantitative image analysis. Fluorescence intensities of the 8-or 16-bit image were analyzed after manually outlining regions of interest (ROI) with the software Image J (NIH, Bethesda, MD). The average fluorescence intensity of a given ROI was measured within the BTX-positive region of the cell and the average fluorescence intensity of an area of the same size positioned over an BTX-negative region outside the cell was subtracted. The measurements for each experimental condition were undertaken on randomly chosen cells, selected from phase contrast images to avoid bias. For illustration purposes, images were processed using Adobe Photoshop, scaled with identical parameters, and pseudo-colored according to a custom designed look-up table (LUT).
RESULTS

AChR endocytosis is accelerated by disruption of AChR/Chol interactions and is independent of cholinergic ligand or antibody binding.
Chol content was shown to modulate cell-surface AChR levels in the CHO-K1/A5 cell line that heterologously expresses adult muscle-type receptor (10) . Chol depletion (Chol -) of these cells with CDx for 30 min at 37°C accelerates the internalization of AChR in a dose-dependent manner (Fig. 1A-B ). This acceleration was abolished when cells were enriched in Chol by treatment with 15 mM CDx-Chol complexes for the same period (Fig. 1) Fig. 1A-B) .
It was previously reported that AChR internalization can be induced by agonists (20) , antagonist (1) and antibody binding (21) (22) (23) . Ligand-triggered endocytosis is a sluggish process in CHO cells, occurring in the time course of hours (10) . No internalization of AChR-BTX complexes is observed within the 30 min time window (Fig. 1C) . The effect of CDx treatment was observed when cells were labeled with αBTX before (Fig. 1C) or after (Fig. 1A-B ) Chol depletion. The same result was obtained when cells were exposed to the full nicotinic agonist carbamoylcholine (Fig. 1C, carb) during CDx treatment, indicating that the Chol-associated acceleration of AChR internalization is independent of ligand (the agonist carbamoylcholine or the antagonist αBTX) binding. To further corroborate this observation, we labeled AChR with the specific antibody mAb210, which binds to the main immunogenic region of the AChR  subunit. As shown in Fig.  1C , AChR internalization is triggered by mAb210 binding (Fig. 1C) . Chol depletion has an additive effect (Fig. 1C) . This series of experiments indicates that Chol depletion accelerates AChR internalization in a ligand-and antibodyindependent manner.
Acceleration of AChR endocytosis is reversible and involves the disruption of
AChR/Chol interactions. In order to test the reversibility of the effect of Chol depletion on AChR internalization, cells were first depleted of Chol and, immediately after, replenished with Chol using Chol-CDx complexes. At the end of the incubation period we monitored the changes in AChR and Chol surface levels ( Fig. 2A) as well as the total cellular Chol content (Fig. 2B) . As shown in the preceding section, surface AChR levels decreased when Chol was removed from the membrane (Fig. 1A and Fig. 2A, CDx) . However, within the time period studied, internalized AChR did not return to the cell surface even upon restoring Chol levels ( Fig.s 2A-B , CDx/CDxChol). It is worth noting that cells recover membrane Chol while the level of total Chol remains low ( Fig. 2A-B , CDx/F12). When cell membrane Chol returns to control levels ( Fig. 2A , CDx/F12 and CDx/CDx-Chol), AChR is no longer internalized at an accelerated rate ( Fig. 2A , CDx/F12 and CDx/CDx-Chol), suggesting that surface membrane Chol is the determining factor that modulates plasmalemmal AChR independently of the total Chol content of the cell.
To further test this hypothesis, an additional experiment was devised to specifically affect the availability of Chol at the cell surface. Unlike CDx, the CDx surrogate, nystatin,an antibiotic that binds to and forms complexes with membranebound Chol, sequesters the neutral lipid without removing it from the membrane (24) . When cells were treated with 50 µg/ml nystatin for 1 h at 37˚C a ~25% diminution of cell-surface AChR was observed (Fig. 2C ). As expected, fPEG-Chol levels were not affected (Fig. 2C) . Treatment of CHO-K1/A5 cells with nystatin also resulted in the loss of surface AChR, although its effect was less apparent than in the case of CDx. This series of experiments indicates that membrane Chol is necessary for AChR stability and that it is the disruption of AChR-Chol interactions rather than the physical removal of Chol from the membrane that accelerates AChR endocytosis.
------------------Figure 2 near here -------------------
Relationship between AChR accelerated internalization induced by CDx and the actin cytoskeleton. CDx treatment has been reported to augment the stability of the sub-membrane cytoskeleton and in particular the actin meshwork (25) . Previous work from our laboratory showed that AChR nano-clusters (< 50 nm in diameter) were randomly distributed at the cell membrane, but acquired long-range (within a 0.25-1.5 µm radius) order upon Chol depletion (15) . These observations led us to speculate on the possible involvement of the cytoskeletal meshwork in this process and prompted us to investigate whether the acceleration of AChR endocytosis under Chol -conditions was associated with actin meshwork reorganization. Cells were co-incubated for 30 min at 37°C with CDx (15 mM) and drugs that inhibit actin polymerization: Latrunculin A (12.5 µM), Cytochalasin D (2.5 µM) (26;27), or Jasplakinolide (1 µM), a drug that promotes actin polymerization (28;29) . None of these drugs by themselves exerted any effect on AChR internalization in Chol-depleted cells over the 30 min period tested here. When stained with rhodamine-labeled phalloidin, a probe of filamentous actin, control cells exhibited the characteristic pattern of actin stress fibers, some immediately adjacent to the cell membrane. The corresponding Alexa 647 -BTX fluorescence was observed only at the cell surface in proximity to the actin stress fibers. Upon treatment of cells with CDx (together with the solvent used for all drugs in this series of experiments, DMSO) Alexa 647 -BTX staining was observed in the form of punctuate structures, compatible with endosomes. Internalized AChRs thus lost any proximity relationship with the actin fibers (Fig. 3A) . When Chol depletion occurred in the presence of Cytochalasin D, actin stress fibers decreased in number and clumped together noticeably, but AChR internalization was not affected (Fig. 3A) . Treatment with 12.5 µM Latrunculin A produced a massive disruption of the stress fibers, phalloidin staining became punctiform and cells rounded up (Fig. 3A) , but AChR endocytosis proceeded as in control cells (Fig. 3B ). As expected, when cells were treated with Jasplakinolide, a drug that induces polymerization of monomeric actin into amorphous masses (28), actin did not stain with the fluorescent phalloidin, since the two molecules compete for the same binding site on actin fibers ( Fig. 2A) . Thus, cells treated with CDx together with Latrunculin A, Cytochalasin D or Jasplakinolide showed the same pattern of AChR internalization as cells treated with CDx alone (Fig. 3A) . They also showed the same reduction in AChR surface levels ( Fig. 3B ), indicating that when cellular Chol levels are reduced, AChR internalization no longer depends on the integrity of the actin cytoskeleton.
The presence of accessory receptor-binding proteins in muscle cells such as rapsyn increases the stability of the AChR in the membrane (30) (31) (32) (33) (34) . Rapsyn is associated with the AChR in a 1:1 stoichiometry and stabilizes the receptor protein by linking it with the cytoskeleton (33;35;36). Since CHO-K1/A5 cells lack rapsyn, it was necessary to discard the possibility that it is the absence of this protein that makes AChR endocytosis sensitive to Chol levels. In order to test this hypothesis, CHO-K1-A5 cells were transfected with a plasmid coding for rapsyn-GFP and AChR internalization was followed in Choldepleted cells. Rapsyn-expressing cells (marked with an asterisk in Supp. Fig. 2) showed the same pattern of internalization as control cells. Moreover, the presence of rapsyn did not alter the number of cells that internalized AChRs when treated with CDx (Supp. Fig. 2 ). These results indicate that the absence of the non-receptor protein rapsyn in CHO cells is not responsible for the sensitivity of AChR internalization to Chol levels.
Internalized AChR is transported to specific endosomes. Upon Chol depletion AChR-BTX complexes were internalized much faster. To elucidate the nature of the structures intervening in AChR endocytosis under Chol -conditions, we performed co-localization studies with markers of different subcellular compartments. Cells were transiently transfected with plasmids coding for the early endosome marker Rab 5-GFP or the late endosome marker Rab7-GFP. Twelve h after transfection, cells were labeled with Alexa 647 -BTX for 1 h at 4°C, washed with medium 1 and treated with 15 mM CDx for 30 min at 37°C. At the end of the incubation period cells were imaged. Some BTX-AChR labeled endosomes were found to co-localize with Rab5-GFP and Rab7-GFP (Fig. 4, upper panel) , making apparent that the receptor-ligand complex is targeted to an endosomal compartment. BTX-AChR labeled endosomes do not colocalize with the lysosome marker Lysotracker during the 30 min incubation, indicating that there is no AChR degradation over this period; no reduction in total AChR levels was observed in Chol -cells up to 1h (Fig. 4,  histogram) . AChR-BTX complexes colocalize with lysosome markers only after this 1h-period (Fig. 4, middle panel) , suggesting that internalized AChR are targeted to degradation. Once internalized, AChR-containing endosomes do not colocalize with fluorescent transferrin (Tfr) or FITC-dextran over the 30 min incubation period, implying that the entry route followed by AChR in Chol -cells does not overlap with the clathrin-and cdc42-dependent pathways (Fig. 4, lower panel) .
Upon Chol depletion, AChR internalization remains independent of the canonical clathrinand dynamin-dependent pathways.
In order to characterize the mechanism underlying the acceleration of cell-surface AChR upon Chol depletion from the membrane, CHO-K1/A5 cells were transiently transfected with the cDNA coding for a dominant negative mutant of dynamin (dynK44A-HA) and a truncated form of Eps15, Eps15Δ95-295-EGFP, which blocks entry of cargo through the clathrin pathway (37;38). As shown previously in cells having normal Chol levels (1), neither dynK44A-HA nor Eps15Δ95-295-EGFP expression affected AChR internalization; however, as expected, internalization of fluorescent Tfr was impaired in cells transfected with either plasmid (Supp. Fig. 3 ). Twelve hours after transfection, cells were labeled with Alexa 647 -BTX at 4°C, and submitted to CDx treatment. Arf6 is a member of the Arf (ADP-ribosylation factor) family of GTP-binding proteins. It is localized at the plasma membrane where it regulates membrane traffic (39) . A clathrinindependent endocytic pathway associated with Arf6 has been described (40) . The next series of experiments was aimed at establishing whether AChR internalization is affected by Arf6 under Chol -conditions. CHO-K1/A5 cells were transiently transfected with a dominant negative (Arf6 T27N-HA) (Fig. 6A ).
----------------Figure 6 near here ---------------------
In order to evaluate the effect of Arf6 inhibition in more detail, we performed a double labeling protocol. Transfected cells were initially labeled with Alexa 568 -BTX (red) at 4°C and subsequently exposed for 30 min at 37°C to CDx or medium 1. At the end of the incubation period cells were labeled with mAb210 anti-AChR antibody and Alexa 647 -secondary antibody (farred). Cells were then fixed, permeabilized, and labeled with anti-HA antibody and Alexa 488 -secondary antibody. According to this protocol, red fluorescence represents total AChR present at the cell surface at the beginning of the experiment and far-red fluorescence corresponds to AChR remaining at the surface at the end of the experiment. Changes in the far-red:red ratio thus provide a quantitative estimation of the degree of AChR internalization. In cells transfected with Arf6T27N and treated with CDx, only ~20% of the AChRs were internalized, a figure similar to that of cells incubated with medium 1 only (Fig.  6C ). This series of experiments provides additional support to the novel observation that CDx enhances the internalization of AChR via an Arf6-dependent mechanism. In contrast, in control cells having normal Chol levels, transfection of dominant negative or constitutive active mutants of Arf6 had no effect on AChR internalization even after 6 h of chase (Fig. 6D) 
CDx-mediated acceleration of AChR endocytosis is dependent on phospholipase D.
Arf6 activation is also coupled with the generation of phosphatidic acid (PA) through phospholipase D (PLD)-mediated hydrolysis of phosphatidylcholine. In the context of membrane trafficking PA is an important lipid involved in the formation and fission of vesicles (46;47) . To elucidate whether the internalization of the AChR in Chol -cells requires the formation of PA, cells were co-incubated with CDx and 1-butanol. Primary alcohols like 1-butanol shift the generation of PA by PLD to the corresponding phosphatidyl alcohol, which is inactive (48) . Alcohols with branched chains, like isobutanol, are not substrates of PLD and were thus used as controls. As shown in Fig.s 7B and C, cells treated with CDx and 0.3% 1-butanol showed an inhibition of AChR internalization, concomitant with an increase in AChR surface levels. However, the use of isobutanol instead of 1-butanol caused no inhibition of AChR internalization (Figs. 7B-C ).
------------------Figure 7 near here -------------------
DISCUSSION
Many steps during the formation of the neuromuscular junction involve changes in the availability of Chol. In a similar manner to when CHO/K1-A5 cells are treated with CDx, membrane cholesterol gradually decreases up to ~45% with the differentiation of C2 cells, such decrease being necessary for myoblast fusion (49) . Chol levels are subsequently recovered and become important in both the formation and stabilization of agrin-induced AChR clusters (11) (12) (13) . In the present work, as in our previous one (10), we dissect the role of Chol in AChR surface stability by reducing membrane cholesterol levels with the cholesterol depleting agent CDx (50) and membrane Chol availability with the Chol sequestering agent, nystatin (24) . Both approaches accelerated AChR internalization.
AChR cell-surface levels are modulated by ligand binding, as shown in various mammalian cell systems as well as in the neuromuscular junction in vivo (1;20;23;51). Binding of the competitive antagonist BTX or antibodymediated crosslinking triggers the internalization of cell-surface AChR in CHO-K1/A5 cells and of endogenous muscle-type AChR in C2C12 myoblasts via a dynamin-, clathrin-, caveolin-and Arf6-independent mechanism (1). This pathway requires the activity of the small GTPase Rac1, the tyrosine kinase c-Src and the integrity of the cytoskeleton (Fig. 8 and ref. 1 ). In contrast, as shown here, AChR internalization in Chol -cells is independent of ligand binding: neither pre-labeling of cells with the antagonist BTX nor binding of the agonist carbamoylcholine or the antibody mAb210 is necessary to induce AChR endocytosis in Chol -cells (Fig. 8) . Thus, cholesterol may constitute an endogenous modulator of AChR surface levels of unliganded cell-surface receptors at the neuromuscular junction. Conversely, interaction of AChR with Chol in the membrane may confer ligand dependence on AChR internalization.
The consequence of Chol depletion on the rate of AChR internalization is unusual (10): whereas this treatment severely hinders most endocytic pathways, the opposite effect, acceleration, appears to be operative in the case of AChR internalization in CHO-K1/A5 cells. Several studies have indicated the need for Chol to maintain AChR conformation and function (10) . Recent dynamic in silico molecular simulations of AChR suggest that the structure collapses in the absence of Chol (52) . Hence, Chol depletion could also be associated with changes in AChR conformation, making it more sensitive to internalization.
The effects of Chol depletion on the plasma membrane are diverse and complex (50) . CDx treatment has been reported to augment the stability of the actin cytoskeleton, an effect related to the redistribution of PI(4,5)P 2 (25) . In CHO-K1/A5 cells with normal Chol levels AChR internalization does require the integrity of the cytoskeleton (1). However, as shown here, when the Chol level is reduced, internalization of AChR proceeds even when the actin cytoskeleton is distressed. Perturbation of actin filaments by Cytochalasin D, Latrunculin A or Jasplakinolide treatment affected neither the rate of AChR internalization nor the gross morphology of AChR-containing endosomes. These data support the notion that Chol depletion may uncouple actin dynamics from AChR internalization kinetics.
Blocking of Arf6 activity inhibited AChR endocytosis in Chol -cells. A decrease in the number of cells that internalize AChR and a reduction in the AChR internalization rate were apparent in cells expressing the dominant negative form of Arf6, Arf6T27N. Under normal Chol levels, however, AChR internalization is insensitive to Arf6 activity. No effects were observed with the constitutively active mutant of Arf6, Arf6Q67L. AChR internalization requires activation of the Rho GTPase Rac1, both in Chol There is increasing evidence of the crosstalk between Arf6 and Rac1 signaling (41;42;45;53-55) . Chol depletion was shown to activate Rac1 (56), mimicking the effect of loss of adhesion (57;58). It is interesting to note that cell adhesion to specific extracellular matrix proteins can lead to the formation of complex AChR clusters very similar to those present in the mature neuromuscular junction (59) . Formation of large, micron-sized clusters of AChR is associated with increased AChR stability and requires Chol (11) (12) (13) (14) . Disruption of lipid domains was shown to destabilize AChR clusters in C2C12 and CHO-K1/A5 cells (10;12;13) . The intervening mechanism is not clear, though loss of AChR association with rapsyn and changes in the state of AChR phosphorylation have been postulated (12) . In the present work the participation of rapsyn has been ruled out: overexpression of rapsyn-GFP does not affect the accelerated AChR endocytosis in Chol -cells. Interestingly, even though the AChR nano-clusters in CHO cells are much smaller than the fully-developed "macro" clusters in the adult muscle synapse, they seem to respond to Chol depletion in a like manner, suggesting a conserved lipid (Chol)-dependence for maintaining AChR stability at the cell surface.
Arf6 GTPase activates the enzyme phospholipase D, which hydrolyzes phosphatidylcholine to produce PA. Due to its geometry, PA has been postulated to be involved in the generation of negative curvature in the membrane, thus facilitating the formation and fission of vesicles (46;47) . When the production of PA was inhibited, a reduction was observed in the internalization of AChR in Chol -cells, indicating that this process does indeed require PA. In other cell systems it was demonstrated that CDx treatment stimulates PLD activity (60) (61) (62) . One could speculate that PLD activation, either directly as a result of Chol depletion or indirectly via coupling to Arf6 activation, increments PA levels in membrane domains in which the AChR resides. This increment might facilitate attainment of the membrane curvature necessary for the formation of endocytic vesicles. PA may also have more specific effects. It has been proposed that AChR organizes its immediate microenvironment in the form of microdomains with higher lateral packing density and rigidity, with a possible competition between Chol and saturated PA for the same binding sites on the AChR protein (63) . Furthermore, PA stabilizes the resting, agonistactivatable conformational state of the AChR (63) , and this lipid is preferred to phosphatidylcholine in the immediate microenvironment of the receptor protein (64) . Thus replacement of Chol by PA in the AChR lipid microenvironment may stabilize the AChR in a conformation that is preferentially internalized by an Arf6-controlled pathway.
Fusion is an essential step during myoblast differentiation, and Arf6 has been shown to modulate C2C12 fusion by regulating PLD enzymatic activity (65). When the same dominantnegative Arf6 mutant that we used in our work (Arf6 T27N) was applied to myoblasts in culture, cells failed to fuse and form myotubes (66) . Thus the biological role -the raison d'être-of the Arf route may entail differentiation-related aspects. The AChR-expressing CHO-K1/A5 cell line developed in our laboratory and used in the present work constitutes a "minimalist" model cell system mimicking the pre-innervation (aneural) embryonic stages of muscle and AChR differentiation (reviewed in Barrantes, 2007) .
Variations in Chol levels occur in muscle cell differentiation: the Chol content of BC3H-1 cells was found to be 94±21 before differentiation (i.e., previous to the cell-surface expression of AChRs) and 124±14 nmol lipid/mg protein in differentiated cells, when AChRs are expressed (67) . Conversely, in differentiated muscle cells Chol depletion induces the fragmentation of the relatively large, micron-sized AChR clusters (11) (12) (13) (14) . AChR clusters are associated with highly ordered / high cholesterol membrane domains in myotubes, distinct from the more fluid surroundings (14) . Diffusion of AChRs from the junctional to the perijunctional region also involves changing the Chol environment of the receptor, which may explain why perijunctional AChRs are more susceptible to internalization than junctional AChRs (51). Thus, although stabilization of AChR at the membrane is considered to occur almost exclusively as a result of specific protein-protein interactions, i.e., anchoring of AChR complexes to components of the cytoskeleton (68-71), cholesterol may not only provide the appropriate lipid microenvironment that allows these interactions to occur but also itself contribute as an AChR-stabilizing factor
In conclusion, the present experiments establish that Chol levels in the membrane are important in determining the endocytic trail followed by AChR. Under Chol -conditions AChR is internalized by a pathway that depends on the activity of the small GTPases Arf6 and Rac1 and 
